MYD88 and diffuse large B-cell lymphoma: The prognostic value of the MYD88 mutation and its correlation with OS has been a matter of debate, as some studies have reported that MYD88 mutation is significantly associated with low survival rates [24, 27, 28], while others identified no effect of MYD88 mutation on the survival of DLBCL patients [29, 30].